Natera Announces Preliminary Fourth Quarter and Full Year 2023 Revenues

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing, today announced preliminary revenue results for the fourth quarter and full year ended Dec. 31, 2023. The Company expects the following: Total revenues of approximately $300 million in the fourth quarter of 2023, an increase of approximately 38$217 million in the fourth quarter of 2022. Total revenues of approximately $1.07 billion in 2023, an increase of approximately 30% compare ...